Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group-Reference-Cited by-同舟云学术

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

Published:2015-11-03 Issue:2 Volume:71 Page:177-184
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Dietel Manfred,Bubendorf Lukas,Dingemans Anne-Marie C,Dooms Christophe,Elmberger Göran,García Rosa Calero,Kerr Keith M,Lim Eric,López-Ríos Fernando,Thunnissen Erik,Van Schil Paul E,von Laffert Maximilian

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference49 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations;Thunnissen;Virchows Arch,2012

3. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer;Davies;Clin Cancer Res,2012

4. Efficacy and safety of crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC);Ou;Ann Oncol,2013

5. Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance;Dietel;Cancer Gene Ther,2013

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Cytology;Pulmonary Pathology;2025

2. Different pathways to lung cancer diagnosis in a real-life setting;Respiratory Medicine and Research;2024-11

3. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

4. Thickness-Resolved Electrochemiluminescence Microscopy of Extracellular Matrix at Tumor Tissues for Rapid Cancer Diagnosis;ACS Applied Materials & Interfaces;2024-06-12

5. Rapid molecular profiling utilising minimal quantities of endobronchial ultrasound‐guided aspirates for the detection of Epidermal Growth Factor Receptor, KRAS, ALK, ROS1, RET, NTRK and MET gene alterations from patients with non‐small‐cell lung carcinomas on the Biocartis Idylla™ platform;Cytopathology;2024-05-30